COUNTERACTION OF RETINOIC ACID AND 1,25-DIHYDROXYVITAMIN-D3 ON UP-REGULATION OF ADIPOCYTE DIFFERENTIATION WITH PPAR-GAMMA LIGAND, AN ANTIDIABETIC THIAZOLIDINEDIONE, IN 3T3-L1 CELLS
Y. Hida et al., COUNTERACTION OF RETINOIC ACID AND 1,25-DIHYDROXYVITAMIN-D3 ON UP-REGULATION OF ADIPOCYTE DIFFERENTIATION WITH PPAR-GAMMA LIGAND, AN ANTIDIABETIC THIAZOLIDINEDIONE, IN 3T3-L1 CELLS, Life sciences, 62(14), 1998, pp. 205-211
Citations number
21
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Retinoic acid (RA) and 1,25-dihydroxyvitamin D3 (1,25 (OH)2 D3) inhibi
ted adipocyte differentiation of 3T3-L1 preadipocytes in the presence
of thiazolidinedione, a specific ligand for peroxisome proliferator-ac
tivated receptor gamma (PPAR gamma). These fat-soluble vitamins repres
sed the upregulated protein expression of PPAR gamma 2 during the firs
t 40 hours of initiation of 3T3-L1 Compared with RA, 1,25 (OH)2 D3 inh
ibited PPAR gamma 2 expression more effectively and caused concomitant
ly a greater inhibition of adipocyte differentiation. These results su
ggest that the inhibitory action of adipocyte differentiation by RA or
1,25 (OH)2 D3 is exhibited through direct repression of the expressio
n of PPAR gamma 2 protein, even in the presence of its They also raise
the intriguing possibility that attenuation or amplification of the p
harmacological effects of thiazolidinedione that are dependent on PPAR
gamma in adipose cells is caused by alteration of the levels of these
fat-soluble vitamins. (C) 1998 Elsevier Science Inc.